Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Check Out What Whales Are Doing With MRNA
Alnylam Pharmaceuticals Analyst Ratings
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
Here Are Big Pharma's Leading Blockbuster Makers
Decoding Moderna's Options Activity: What's the Big Picture?
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Here's How Much $1000 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,100 Today
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday
Arrowhead Pharma Analyst Ratings
Peering Into Alnylam Pharmaceuticals's Recent Short Interest
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
J&J Beats in Q2 as Pharma Segment Outperforms
Incyte, Moderna Among Most Shorted S&P 500 Healthcare Stocks in June
Solid Biosciences up 10% Following J.P. Morgan Upgrade
The Latest Analyst Ratings For Legend Biotech
Legend Biotech Analyst Ratings